These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2309815)

  • 1. Labetalol pharmacokinetics in pregnancy-induced hypertension.
    Rogers RC; Sibai BM; Whybrew WD
    Am J Obstet Gynecol; 1990 Feb; 162(2):362-6. PubMed ID: 2309815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.
    Prevost RR; Akl SA; Whybrew WD; Sibai BM
    Pharmacotherapy; 1992; 12(3):174-7. PubMed ID: 1608848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of labetalol in the pregnant sheep.
    Yeleswaram K; Rurak DW; Hall C; Wright MR; Axelson JE
    J Pharmacol Exp Ther; 1992 Aug; 262(2):683-91. PubMed ID: 1501116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labetalol disposition and concentration-effect relationships during pregnancy.
    Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
    Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section.
    Gonçalves PVB; Moreira FL; Benzi JRL; Duarte G; Lanchote VL
    J Clin Pharmacol; 2020 Dec; 60(12):1655-1661. PubMed ID: 32562572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of the adrenergic blocker metoprolol in the late-pregnant woman, the amniotic fluid, the cord blood and the neonate.
    Lindeberg S; Sandström B; Lundborg P; Regårdh CG
    Acta Obstet Gynecol Scand Suppl; 1984; 118():61-4. PubMed ID: 6587729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow.
    Nylund L; Lunell NO; Lewander R; Sarby B; Thornström S
    Acta Obstet Gynecol Scand Suppl; 1984; 118():71-3. PubMed ID: 6587732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis.
    Kokot F; Ulman I; Wiecek A; Irzyniec T; Ulman J
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):311-6. PubMed ID: 9832071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenoxybenzamine placental transfer during the third trimester.
    Santeiro ML; Stromquist C; Wyble L
    Ann Pharmacother; 1996 Nov; 30(11):1249-51. PubMed ID: 8913406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of labetalol into amniotic fluid and breast milk in lactating women.
    Lunell NO; Kulas J; Rane A
    Eur J Clin Pharmacol; 1985; 28(5):597-9. PubMed ID: 4043203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of ethanol in maternal blood, fetal blood, and amniotic fluid of third-trimester pregnant ewes.
    Brien JF; Clarke DW; Richardson B; Patrick J
    Am J Obstet Gynecol; 1985 Jul; 152(5):583-90. PubMed ID: 4014353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension.
    Teramo KA; Hiilesmaa VK; Schwartz R; Clemons GK; Widness JA
    J Perinat Med; 2004; 32(3):240-7. PubMed ID: 15188798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
    Clark SM; Dunn HE; Hankins GD
    Semin Perinatol; 2015 Nov; 39(7):548-55. PubMed ID: 26344738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.
    Filgueira GCO; Filgueira OAS; Carvalho DM; Marques MP; Moisés ECD; Duarte G; Lanchote VL; Cavalli RC
    Br J Clin Pharmacol; 2017 Jul; 83(7):1571-1579. PubMed ID: 28042936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia.
    Barton JR; Prevost RR; Wilson DA; Whybrew WD; Sibai BM
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):951-4. PubMed ID: 1951561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive microbore high-performance liquid chromatographic assay for labetalol in the biological fluids of pregnant sheep.
    Yeleswaram K; Axelson JE; Rurak DW
    J Chromatogr; 1991 Apr; 565(1-2):383-90. PubMed ID: 1874882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-life of maternal labetalol in a premature infant.
    Haraldsson A; Geven W
    Pharm Weekbl Sci; 1989 Dec; 11(6):229-31. PubMed ID: 2616255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical examinations of amniotic fluid in arterial hypertension and delayed intrauterine fetal growth. III. Acid-base equilibrium and ionic composition].
    Kuczyńska-Sicińska J; Wójcicka-Jagodzińska J; Romejko E; Smolarczyk R; Siekierski BP
    Ginekol Pol; 1989 Mar; 60(3):137-41. PubMed ID: 2806966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.